Nancy Osland

Nancy Osland has over 17 years of experience in financial planning and analysis. Currently serving as the Director of Financial Planning and Analysis at Prime Therapeutics since May 2014, Nancy has previously held roles including Finance Manager and Sr. Financial Analyst within the same organization. Prior to that, Nancy worked at Thomson Reuters as a Lead Financial Analyst from April 2008 to May 2014 and gained earlier experience as a Sr. Financial Analyst at GMAC ResCap from 2006 to 2008.